Metraipolis › archive › dc_8273dbbe31ba
Bridging pathogenesis and therapy in focal segmental glomerulosclerosis: the rise of dual receptor blockade with sparsentan — Europe PMC PMID:42433793
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42433793
- DOI
- 10.1097/ms9.0000000000005263
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-19T09:45:06.422Z
- SHA-256 of the archived text
d5fe09c1e77995611b178f63cb0584c7c1104772fad487287f1cac8d2ffd685f- Stable URL of this page
https://metraipolis.com/documento/dc_8273dbbe31ba
How to cite
Bridging pathogenesis and therapy in focal segmental glomerulosclerosis: the rise of dual receptor blockade with sparsentan — Europe PMC PMID:42433793 — Europe PMC (en), https://europepmc.org/article/MED/42433793 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8273dbbe31ba (Metraipolis archive dc_8273dbbe31ba, sha256 d5fe09c1e77995611b178f63cb0584c7c1104772fad487287f1cac8d2ffd685f)
BibTeX
@misc{dc8273dbbe31ba,
title = {Bridging pathogenesis and therapy in focal segmental glomerulosclerosis: the rise of dual receptor blockade with sparsentan — Europe PMC PMID:42433793},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42433793},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8273dbbe31ba; sha256 d5fe09c1e77995611b178f63cb0584c7c1104772fad487287f1cac8d2ffd685f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42433793. Agents can read the archived copy with the MCP tool read_document.